Ohio imposes strict rule on workers' back surgery, opioids

January 10, 2018 by Julie Carr Smyth

Ohio residents with work-related back injuries in most cases must try remedies like rest, physical therapy and chiropractic care before turning to spinal fusion surgery and prescription painkillers under a groundbreaking new guideline that is partly meant to reduce the overprescribing of opioids but isn't sitting well with everyone.

Washington, Colorado and Minnesota already restrict injured-worker payments for the surgery, officials said, but the Ohio policy, which went into effect Jan. 1, goes further by embedding an opioid warning specifically into its surgical restriction. The state has been among the hardest hit by the overdose crisis, which many experts say stems largely from addictions to prescription painkillers that can progress into heroin use.

At issue is a procedure in which portions of the patient's spine are fused permanently to address certain conditions, including degenerative disc disease and severe chronic low back pain. Injured Ohio workers get such surgery about 600 times a year.

The new rule at the Ohio Bureau of Workers Compensation, the nation's largest state-run injured-worker fund, requires an injured worker to undergo at least 60 days of alternative care—while avoiding opioid use, if possible—before resorting to spinal fusion surgery, with a few exceptions for the most severe back injuries. By including the opioid warning, it's a more aggressive restriction than other states that also decline to pay right away for the surgery.

Daniel Resnick, a Madison, Wisconsin-based neurosurgeon and president of the North American Spine Society, said the Ohio rule is overly broad and will result in added hurdles for those in need of spinal fusion surgery.

"Lumbar fusion works extremely well for a few things," he said. "It doesn't work well for everything, and it doesn't work well for every patient, but in those cases where it's appropriate, this is an unsophisticated rule that's going to add an administrative burden—added time, added costs—for the patient. They'll be futzing around wasting two months rather than getting the effective treatment they need."

But the bureau defends the decision.

Studies have shown that fewer than half of patients are able to return to work after the surgery and that it is often ineffective or followed by complications. Afterward, workers' pain oftentimes continues—or even gets worse.

"We now have better knowledge of who responds better to surgery, and we also know that some patients actually require more opioid medication after surgery than they did before surgery," said Terrence Welsh, the Ohio injured worker bureau's chief medical officer.

That's exactly the opposite of what injured worker funds want. A survey by CompPharma last year showed workers compensation insurers view opioids and addiction as the industry's most pressing concern. Their spending on opioids topped $1.5 billion in 2015.

An Associated Press review of more than a decade of opioid prescription data from injured-worker systems in three states—Ohio, California and Texas—found varying degrees of success. The information was provided to the AP through public records requests.

The analysis showed:

— Ohio has touted that 44 percent fewer injured workers received opioids in the past five years, saving $46 million in drug costs, as rules were imposed allowing denial of reimbursement for opioid prescriptions if physicians are believed to be overprescribing or otherwise failing to follow "best medical practices" in treating injured workers. Data showed much of that decline coincided with the steep drop in the overall number of injured workers in the state—from 81,000 in 2007 to 38,000 in 2016. The percentage of injured workers on prescription narcotics over that time fell seven percentage points, from 75 to 68 percent.

— In Texas, opioid prescriptions for workers decreased more than Ohio, as the number of injured workers fell from 183,000 in 2007 to 119,000 to 2016, or 35 percent, while the percentage of workers on opioid prescriptions fell 11 percentage points, from 63 percent to 52 percent.

— In California, the trend contrasts with Ohio, as data for the same time period showed the percentage of workers on opioid prescriptions rose slightly, from 35 percent to 37 percent, but that was as the injured worker population rose 12 percent, from 332,000 to 368,000.

Chris Thomshack, CEO and founder of HealthSource, a large chiropractic-clinic chain, said narcotic use has been found to increase 41 percent in patients who received fusion surgery and to continue over two years in three-quarters of patients.

"Non-invasive treatments for chronic back pain, including chiropractic care, have proven to deliver better outcomes for most patients based on numerous studies," said Thomshack, a physician. "Ohio is taking the lead with its BWC ruling, which will reduce lost productivity and costs to the state, and most importantly, improve the healing process for injured workers."

Explore further: Fewer injured workers getting opioid prescriptions in some states

Related Stories

Fewer injured workers getting opioid prescriptions in some states

June 13, 2016
(HealthDay)—As the United States continues to grapple with the painkiller addiction epidemic, a new study reports that fewer injured workers are getting prescriptions for opioids in most of the 25 states included in the ...

Ohio awards $10M to boost opioid, addiction breakthroughs

December 7, 2017
Ohio will pay to support development of pain management alternatives, mobile apps to improve addiction treatment and other advanced technologies through $10 million in competitive grants.

Drug may help surgical patients stop opioids sooner

December 13, 2017
(HealthDay)—Opioid painkillers after surgery can be the first step toward addiction for some patients. But a common drug might cut the amount of narcotics that patients need, a new study finds.

Ohio to name winners of up to $12M in opioid science grants

December 7, 2017
Ohio is set to name recipients of up to $12 million in competitive grants aimed at supporting scientific breakthroughs to solve the national opioid crisis.

Postsurgery guideline could reduce opioid prescriptions by as much as 40 percent

November 30, 2017
Rising rates of opioid prescriptions have been linked to the opioid epidemic, and a significant number of opioid deaths have been linked to prescriptions written by surgeons. However, new study results suggest that a more ...

Patients taking opioids prior to ACL surgery more likely to be on pain medications longer

July 22, 2017
More than 130,000 Anterior Cruciate Ligament (ACL) surgeries take place each year with the majority of patients not requiring pain medication after three months post-operatively. However, researchers presenting their work ...

Recommended for you

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

Price tag on gene therapy for rare form of blindness: $850K

January 3, 2018
A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting ...

Restasis: Why US consumers paid billions for drug deemed ineffective in other countries

January 2, 2018
Why are Americans, both as patients and taxpayers, paying billions of dollars for a drug whose efficacy is so questionable that it's not approved in the European Union, Australia or New Zealand? Restasis, a blockbuster drug ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.